Sicart Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
SAM
AIM
GI
DRZID
Sicart Associates's DBD Position: Q3 2017 in Review
Sicart Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2017, closing a stake of 8,300 shares — an estimated $232K sold.
Sicart Associates first reported a position in DBD in Q4 2016 and held it in 3 quarters. The position peaked at $272K in Q4 2016. 226 funds tracked by Wall St. Rank hold DBD as of Q3 2017.
- Sicart Associates reported no remaining Diebold Nixdorf Incorporated position as of Q3 2017 after selling out during the quarter.
- Sicart Associates sold 8,300 Diebold Nixdorf Incorporated shares in Q3 2017, an estimated $232K.
- Sicart Associates first reported a position in Diebold Nixdorf Incorporated in Q4 2016 and held it in 3 quarters.
- Sicart Associates's Diebold Nixdorf Incorporated position peaked at $272K in Q4 2016.
- 226 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2017.
Based on Sicart Associates's 13F filing for Q3 2017, filed 6 Nov 2017.